BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6212543)

  • 1. An empirical analysis of HMO market share.
    Morrisey MA; Ashby CS
    Inquiry; 1982; 19(2):136-49. PubMed ID: 6212543
    [No Abstract]   [Full Text] [Related]  

  • 2. Unbridled managed care: when consumers experience antitrust welfare loss from exclusionary contracts between HMO insurers and health care providers.
    Ruskin A
    Health Matrix Clevel; 1996; 6(2):391-469. PubMed ID: 10178393
    [No Abstract]   [Full Text] [Related]  

  • 3. Whither managed care?
    Berlin B
    N J Med; 1997 May; 94(5):27-30. PubMed ID: 9164101
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring the economic value of HMOs.
    Beauregard TR
    Benefits Q; 1995; 11(2):16-8. PubMed ID: 10142757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determinants of HMO enrollment and growth.
    Goldberg LG; Greenberg W
    Health Serv Res; 1981; 16(4):421-38. PubMed ID: 7327943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What lies beneath. Addressing hidden costs of physician/HMO conflict.
    Diamond F
    Manag Care; 2001 Jun; 10(6):32-3, 37-40. PubMed ID: 11431968
    [No Abstract]   [Full Text] [Related]  

  • 7. Managed indemnity insurance--a clear choice for health plan sponsors.
    Westfall DJ
    Empl Benefits J; 1997 Dec; 22(4):26-8. PubMed ID: 10179412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "group of groups" describes the HMO, Intergroup.
    Employee Benefit Plan Rev; 1977 Jun; 31(12):48-9. PubMed ID: 10304798
    [No Abstract]   [Full Text] [Related]  

  • 9. Marketplace. Long-term HMO contracts promise better value for all.
    Moskowitz DB
    Faulkner Grays Med Health; 1997 Jul; 51(29):suppl 2 p.. PubMed ID: 10168593
    [No Abstract]   [Full Text] [Related]  

  • 10. Designing benefits that are good for employees and for business.
    Kreig J; Hergenrader R
    Health Care Strateg Manage; 1997 Oct; 15(10):1, 21-3. PubMed ID: 10173409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMO marketing: the Cadillac and the Chevy.
    Holt M
    Physician Exec; 1988; 14(1):21-4. PubMed ID: 10312409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marketing managed care to retirees.
    Moskowitz DB
    Bus Health; 1997 Sep; 15(9):29-30, 33-4, 36. PubMed ID: 10173231
    [No Abstract]   [Full Text] [Related]  

  • 13. HMO appeal. Could you get more care for your cash?
    Brazil JH
    Manage World; 1985 Mar; 14(3):36-7. PubMed ID: 10270396
    [No Abstract]   [Full Text] [Related]  

  • 14. Case study. The little HMO that could: heart of America HMO in Rugby, North Dakota.
    Sternberg L
    Health Syst Lead; 1995 Nov; 2(9):16-22. PubMed ID: 10152495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the HMO-benefits managers relationship: what to measure and why.
    Peltier JW; Westfall J
    Mark Health Serv; 2000; 20(2):4-13. PubMed ID: 11183429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBM industry today: who's managing drug costs?
    Martin SS
    Manag Care; 2001 Dec; 10(12):36-8. PubMed ID: 11795000
    [No Abstract]   [Full Text] [Related]  

  • 17. Employers cautiously optimistic on HMO potential for cost containment.
    Ibbs PJ
    Employee Benefit Plan Rev; 1978 Apr; 32(10):10, 12. PubMed ID: 10306659
    [No Abstract]   [Full Text] [Related]  

  • 18. Broker appeal.
    Rush B
    HMO; 1995; 36(4):75-7. PubMed ID: 10166491
    [No Abstract]   [Full Text] [Related]  

  • 19. The "selling" of an HMO.
    Van Bell RJ
    Bus Health; 1984; 1(3):18-20. PubMed ID: 10265688
    [No Abstract]   [Full Text] [Related]  

  • 20. Insurance market reform: what's ahead?
    O'Neil-White A; Carneal G
    HMO; 1995; 36(1):21-3. PubMed ID: 10152501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.